ES2647488T4 - Procedimiento de producción de pastillas que contienen AINE, sus composiciones, su uso medicinal - Google Patents
Procedimiento de producción de pastillas que contienen AINE, sus composiciones, su uso medicinal Download PDFInfo
- Publication number
- ES2647488T4 ES2647488T4 ES06709907T ES06709907T ES2647488T4 ES 2647488 T4 ES2647488 T4 ES 2647488T4 ES 06709907 T ES06709907 T ES 06709907T ES 06709907 T ES06709907 T ES 06709907T ES 2647488 T4 ES2647488 T4 ES 2647488T4
- Authority
- ES
- Spain
- Prior art keywords
- compositions
- production procedure
- medicinal use
- pills containing
- containing nsaids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 title 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 title 1
- 239000006187 pill Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0504157 | 2005-03-01 | ||
| GB0504157A GB2423710A (en) | 2005-03-01 | 2005-03-01 | Lozenge production process |
| PCT/GB2006/000680 WO2006092569A1 (en) | 2005-03-01 | 2006-02-27 | Production process for nsaid-containing lozenges, their compositions, their medicinal use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ES2647488T3 ES2647488T3 (es) | 2017-12-21 |
| ES2647488T5 ES2647488T5 (es) | 2023-08-09 |
| ES2647488T4 true ES2647488T4 (es) | 2024-01-16 |
Family
ID=34430399
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES17185774T Active ES2886323T3 (es) | 2005-03-01 | 2006-02-27 | Proceso de producción de pastillas que contienen AINE |
| ES06709907T Active ES2647488T4 (es) | 2005-03-01 | 2006-02-27 | Procedimiento de producción de pastillas que contienen AINE, sus composiciones, su uso medicinal |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES17185774T Active ES2886323T3 (es) | 2005-03-01 | 2006-02-27 | Proceso de producción de pastillas que contienen AINE |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US10328039B2 (es) |
| EP (3) | EP3284458B1 (es) |
| JP (1) | JP2008531664A (es) |
| KR (2) | KR101358687B1 (es) |
| CN (2) | CN103156818A (es) |
| AU (1) | AU2006219777B2 (es) |
| CA (1) | CA2599861A1 (es) |
| DK (1) | DK1853220T3 (es) |
| ES (2) | ES2886323T3 (es) |
| GB (1) | GB2423710A (es) |
| HU (1) | HUE034872T2 (es) |
| MX (1) | MX2007009275A (es) |
| MY (1) | MY154770A (es) |
| PL (2) | PL3284458T3 (es) |
| PT (1) | PT1853220T (es) |
| RU (1) | RU2403032C2 (es) |
| SG (1) | SG161201A1 (es) |
| SI (2) | SI3284458T1 (es) |
| TW (1) | TWI372065B (es) |
| WO (1) | WO2006092569A1 (es) |
| ZA (1) | ZA200706067B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090104236A1 (en) * | 2007-10-18 | 2009-04-23 | Pharmaceutics International, Inc. | Pharmaceutical solid hybrids |
| GB201215988D0 (en) * | 2012-09-07 | 2012-10-24 | Reckitt Benckiser Healthcare Int Ltd | Pharmaceutical compositions comprising flurbiprofen |
| US9914968B2 (en) | 2012-09-26 | 2018-03-13 | Cepheid | Honeycomb tube |
| FR2997856B1 (fr) * | 2012-11-14 | 2015-04-24 | Pf Medicament | Pastille medicamenteuse a base d'ibuprofene sodique dihydrate |
| US20220313710A1 (en) * | 2019-08-22 | 2022-10-06 | Applied Biological Laboratories, Inc. | Compositions and methods using non-steroidal anti-inflammatory drugs |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1084864A (en) * | 1964-02-06 | 1967-09-27 | Merck & Co Inc | Medicated lozenges |
| US5071643A (en) * | 1986-10-17 | 1991-12-10 | R. P. Scherer Corporation | Solvent system enhancing the solubility of pharmaceuticals for encapsulation |
| GB8813682D0 (en) * | 1988-06-09 | 1988-07-13 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions |
| US5028625A (en) * | 1989-06-20 | 1991-07-02 | American Home Products Corporation | Acid addition salt of ibuprofen and meglumine |
| US5210099A (en) * | 1991-02-11 | 1993-05-11 | American Home Products Corporation | Analgesic compositions |
| US5302394A (en) * | 1992-07-14 | 1994-04-12 | Mcneil-Ppc, Inc. | Dextromethorphan continuous lozenge manufacturing process |
| GB9523833D0 (en) * | 1995-11-22 | 1996-01-24 | Boots Co Plc | Medical treatment |
| AU8107998A (en) * | 1997-05-22 | 1998-12-11 | Boots Company Plc, The | Pharmaceutical compositions |
| GB9710521D0 (en) * | 1997-05-22 | 1997-07-16 | Boots Co Plc | Process |
| DE19735126C1 (de) * | 1997-08-13 | 1999-01-21 | Infectopharm Arzneimittel Und | Verfahren zur Herstellung einer eine Zinkverbindung enthaltenden oralen Zusammensetzung und deren Verwendung zur Behandlung von Erkältungskrankheiten |
| CA2419592A1 (en) * | 2000-08-18 | 2002-02-28 | Pharmacia Corporation | Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor |
| US6689382B2 (en) | 2002-05-15 | 2004-02-10 | Procaps S.A. | Soft shell gelatin capsules containing non-steroidal anti-inflammatories |
| US20070190153A1 (en) | 2004-03-05 | 2007-08-16 | Jonathan Farber | Delivery systems for non-steroidal anti-inflammatory drugs (nsaids) |
-
2005
- 2005-03-01 GB GB0504157A patent/GB2423710A/en not_active Withdrawn
-
2006
- 2006-02-27 HU HUE06709907A patent/HUE034872T2/hu unknown
- 2006-02-27 CN CN2013100515272A patent/CN103156818A/zh active Pending
- 2006-02-27 ES ES17185774T patent/ES2886323T3/es active Active
- 2006-02-27 ES ES06709907T patent/ES2647488T4/es active Active
- 2006-02-27 RU RU2007136106/15A patent/RU2403032C2/ru active
- 2006-02-27 AU AU2006219777A patent/AU2006219777B2/en active Active
- 2006-02-27 US US11/817,716 patent/US10328039B2/en active Active
- 2006-02-27 CA CA002599861A patent/CA2599861A1/en not_active Abandoned
- 2006-02-27 JP JP2007557571A patent/JP2008531664A/ja active Pending
- 2006-02-27 PL PL17185774T patent/PL3284458T3/pl unknown
- 2006-02-27 KR KR1020077020008A patent/KR101358687B1/ko active IP Right Grant
- 2006-02-27 DK DK06709907.7T patent/DK1853220T3/da active
- 2006-02-27 EP EP17185774.1A patent/EP3284458B1/en active Active
- 2006-02-27 SI SI200632408T patent/SI3284458T1/sl unknown
- 2006-02-27 PT PT67099077T patent/PT1853220T/pt unknown
- 2006-02-27 EP EP10158743A patent/EP2210587A1/en not_active Withdrawn
- 2006-02-27 SI SI200632222T patent/SI1853220T2/sl unknown
- 2006-02-27 CN CNA200680006451XA patent/CN101132762A/zh active Pending
- 2006-02-27 KR KR1020147000150A patent/KR20140011422A/ko not_active Application Discontinuation
- 2006-02-27 TW TW095106719A patent/TWI372065B/zh not_active IP Right Cessation
- 2006-02-27 EP EP06709907.7A patent/EP1853220B2/en active Active
- 2006-02-27 PL PL06709907.7T patent/PL1853220T5/pl unknown
- 2006-02-27 MX MX2007009275A patent/MX2007009275A/es active IP Right Grant
- 2006-02-27 SG SG201001311-8A patent/SG161201A1/en unknown
- 2006-02-27 WO PCT/GB2006/000680 patent/WO2006092569A1/en active Application Filing
- 2006-02-28 MY MYPI20060855A patent/MY154770A/en unknown
-
2007
- 2007-07-23 ZA ZA200706067A patent/ZA200706067B/xx unknown
-
2019
- 2019-06-24 US US16/449,856 patent/US10933040B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0809977A2 (pt) | Uso de um composto, compostos e composição farmacêutica que o contém | |
| BRPI0809667A2 (pt) | Composto, medicamento e composição farmacêutica que o contém e uso do composto | |
| BRPI0815079A2 (pt) | Composto dericado de 1,2-diamido-etileno, composição farmacêutica que contém e uso desse composto | |
| BRPI0814593A2 (pt) | Composto, composição farmacêutica que o contém e uso do composto. | |
| ITBO20050123A1 (it) | Formulazioni farmaceutiche gastroresistenti contenenti rifaximina | |
| BRPI0714539A2 (pt) | "formas farmacêuticas" | |
| BRPI0609802A2 (pt) | composto, composição farmacêutica e uso de um composto | |
| BRPI0810696A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
| BRPI0716171A2 (pt) | composto, composiÇço farmacÊutica e uso de um composto. | |
| BRPI0820519A2 (pt) | intermediário para a síntese do análogo de halicondrina b e reação de dessulfonilação usada para o intermediário | |
| BRPI0815170A2 (pt) | Composição farmacêutica que compreende um inibidor de sglt 2 | |
| RU2398586C3 (ru) | Фармацевтическая композиция | |
| BRPI0815709A2 (pt) | composro, composição farmacêutica, e, uso de um composto. | |
| CR10149A (es) | Agentes citotóxicos que comprenden nuevos derivados de tomaimicina y su uso terapéutico | |
| DK2063868T3 (da) | Farmaceutiske sammensætninger indeholdende rosuvastatin-calcium | |
| CL2007003423A1 (es) | Compuestos derivados de pirimidinas sustituidas; proceso para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de artritis reumatoidea, aterosclerosis, entre otras enfermeda | |
| CR10229A (es) | Derivados de 1,2,4,5,-tetrahidro-3h-benzazepinas, su procedimiento de preparación y las composiciones farmacéuticas que las contienen | |
| BRPI0917661A2 (pt) | produto que contém macitentan, composição farmacêutica que o contém e uso de macitentan | |
| BRPI0614730A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| CL2007002377A1 (es) | Compuestos derivados de quinazolina; procedimiento de preparacion; composicion farmaceutica; y su uso como anticancerigeno. | |
| BRPI0813341A2 (pt) | " uso de compostos, composições curáveis, e, uso de composições curáveis ". | |
| CR10725A (es) | Compuestos de pirazolina y su uso y composiones farmaceuticas | |
| BRPI0810019A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
| BRPI0717369A2 (pt) | Composto, medicamento, composição farmacêutica que o contém e uso do composto. | |
| BRPI0716698A2 (pt) | Composto, composição farmacêutica e uso de um composto |